Extracellular Vesicles Released by Cardiomyocytes in a Doxorubicin-Induced Cardiac Injury Mouse Model Contain Protein Biomarkers of Early Cardiac Injury

Authors

Chontida Yarana, University of KentuckyFollow
Dustin W. Carroll, University of KentuckyFollow
Jing Chen, University of KentuckyFollow
Luksana Chaiswing, University of KentuckyFollow
Yanming Zhao, University of KentuckyFollow
Teresa Noel, University of KentuckyFollow
Michael Alstott, University of KentuckyFollow
Younsoo Bae, University of KentuckyFollow
Emily V. Dressler, University of KentuckyFollow
Jeffrey A. Moscow, National Cancer Institute
D. Allan Butterfield, University of KentuckyFollow
Haining Zhu, University of KentuckyFollow
Daret K. St. Clair, University of KentuckyFollow

Abstract

Purpose—Cardiac injury is a major cause of death in cancer survivors, and biomarkers for it are detectable only after tissue injury has occurred. Extracellular vesicles (EV) remove toxic biomolecules from tissues and can be detected in the blood. Here, we evaluate the potential of using circulating EVs as early diagnostic markers for long-term cardiac injury.

Experimental Design—Using a mouse model of doxorubicin (DOX)-induced cardiac injury, we quantified serum EVs, analyzed proteomes, measured oxidized protein levels in serum EVs released after DOX treatment, and investigated the alteration of EV content.

Results—Treatment with DOX caused a significant increase in circulating EVs (DOX_EV) compared with saline-treated controls. DOX_EVs exhibited a higher level of 4-hydroxynonenal adducted proteins, a lipid peroxidation product linked to DOX-induced cardiotoxicity. Proteomic profiling of DOX_EVs revealed the distinctive presence of brain/heart, muscle, and liver isoforms of glycogen phosphorylase (GP), and their origins were verified to be heart, skeletal muscle, and liver, respectively. The presence of brain/heart GP (PYGB) in DOX_EVs correlated with a reduction of PYGB in heart, but not brain tissues. Manganese superoxide dismutase (MnSOD) overexpression, as well as pretreatment with cardioprotective agents and MnSOD mimetics, resulted in a reduction of EV-associated PYGB in mice treated with DOX. Kinetic studies indicated that EVs containing PYGB were released prior to the rise of cardiac troponin in the blood after DOX treatment, suggesting that PYGB is an early indicator of cardiac injury.

Conclusion—EVs containing PYGB are an early and sensitive biomarker of cardiac injury.

Document Type

Article

Publication Date

4-2018

Notes/Citation Information

Published in Clinical Cancer Research, v. 24, issue 7, 1644-1653.

© 2017 American Association for Cancer Research

The copyright holder has granted the permission for posting the article here.

The document available for download is the authors' post-peer-review final draft of the article.

Digital Object Identifier (DOI)

https://doi.org/10.1158/1078-0432.CCR-17-2046

Funding Information

This study was supported by the NIH (RO1 CA139843 to DK St. Clair), the University of Kentucky Markey Cancer Center's Redox Metabolism Shared Resource Facility (P30 CA177558), and the Royal Thai Government Scholarship (Ministry of Science and Technology) to C. Yarana. LC/MS-MS equipment was acquired using a National Center for Research Resources High-End Instrumentation grant (1S10RR029127 to H. Zhu).

Related Content

Supplementary data for this article are available at Clinical Cancer Research Online (http://clincancerres.aacrjournals.org/).

Repository Citation

Yarana, Chontida; Carroll, Dustin W.; Chen, Jing; Chaiswing, Luksana; Zhao, Yanming; Noel, Teresa; Alstott, Michael; Bae, Younsoo; Dressler, Emily V.; Moscow, Jeffrey A.; Butterfield, D. Allan; Zhu, Haining; and St. Clair, Daret K., "Extracellular Vesicles Released by Cardiomyocytes in a Doxorubicin-Induced Cardiac Injury Mouse Model Contain Protein Biomarkers of Early Cardiac Injury" (2018). Toxicology and Cancer Biology Faculty Publications. 82.
https://uknowledge.uky.edu/toxicology_facpub/82